IFNG and neoplasm: In accordance with the fact that miR155 is required by tumor growth and IFN-γ production of T cells within tumor microenvironment [23], our data suggested a functional interaction between tumor cells and CD8+T cells through miR155-PD-L1 regulatory axis, leading to the sensitization of B-lymphoma to anti-PD-L1 antibody.